Cited by 1,275Liver Disease Diagnosis and TreatmentUltrasound Imaging and ElastographyUltrasound in Clinical Applications

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Open access

Karlas, Thomas, Petroff, David, Sasso, Magali, Fan, Jian-Gao, Mi, Yu-Qiang, de Lédinghen, Victor, Kumar, Manoj, Lupsor-Platon, Monica, Han, Kwang-Hyub, Cardoso, Ana C., Ferraioli, Giovanna, Chan, Wah-Kheong, Wong, Vincent Wai-Sun, Myers, Robert P., Chayama, Kazuaki, Friedrich-Rust, Mireen, Beaugrand, Michel, Shen, Feng, Hiriart, Jean-Baptiste, Sarin, Shiv K., Badea, Radu, Jung, Kyu Sik, Marcellin, Patrick, Filice, Carlo, Mahadeva, Sanjiv, Wong, Grace Lai-Hung, Crotty, Pam, Masaki, Keiichi, Bojunga, Joerg, Bedossa, Pierre, Keim, Volker, Wiegand, Johannes·2017·Journal of Hepatology

DOI 10.1016/j.jhep.2016.12.022

Open this paper in CoChat — free account

Abstract

Background & aims The prevalence of fatty liver underscores the need for non-invasive characterization of steatosis, such as the ultrasound based controlled attenuation parameter (CAP). Despite good diagnostic accuracy, clinical use of CAP is limited due to uncertainty regarding optimal cut-offs and the influence of covariates. We therefore conducted an individual patient data meta-analysis.Methods A review of the literature identified studies containing histology verified CAP data (M probe, vibration controlled transient elastography with FibroScan®) for grading of steatosis (S0-S3). Receiver operating characteristic analysis after correcting for center effects was used as well as mixed models to test the impact of covariates on CAP. The primary outcome was establishing CAP cut-offs for distinguishing steatosis grades.Results Data from 19/21 eligible papers were provided, comprising 3830/3968 (97%) of patients. Considering data overlap and exclusion criteria, 2735 patients were included in the final analysis (37% hepatitis B, 36% hepatitis C, 20% NAFLD/NASH, 7% other). Steatosis distribution was 51%/27%/16%/6% for S0/S1/S2/S3. CAP values in dB/m (95% CI) were influenced by several covariates with an estimated shift of 10 (4.5-17) for NAFLD/NASH patients, 10 (3.5-16) for diabetics and 4.4 (3.8-5.0) per BMI unit. Areas under the curves were 0.823 (0.809-0.837) and 0.865 (0.850-0.880) respectively. Optimal cut-offs were 248 (237-261) and 268 (257-284) for those above S0 and S1 respectively.Conclusions CAP provides a standardized non-invasive measure of hepatic steatosis. Prevalence, etiology, diabetes, and BMI deserve consideration when interpreting CAP. Longitudinal data are needed to demonstrate how CAP relates to clinical outcomes.Lay summary There is an increase in fatty liver for patients with chronic liver disease, linked to the epidemic of the obesity. Invasive liver biopsies are considered the best means of diagnosing fatty liver. The ultrasound based controlled attenuation parameter (CAP) can be used instead, but factors such as the underlying disease, BMI and diabetes must be taken into account. Registration: Prospero CRD42015027238.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2016.12.022

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statisctics and computing/Statistics and computing · doi:10.1007/978-0-387-21706-2 · Cited by 25,941
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Fitting Linear Mixed-Effects Models Using lme4Preprint
Bates, D. M., Maechler, M., Bolker, B. M., & Walker, S. (2014) · arXiv (Cornell University) · doi:10.3929/ethz-b-000105397 · Cited by 9,435
Histological grading and staging of chronic hepatitis.
Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,854
Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
Bédossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,189
AASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2015) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,002

Flagged first, then by citations

Show all 65 references

1 of the 65 references couldn’t be matched to a known paper.

Sorted by citations

Items 601–700 of 1,000

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease
Hsieh, M.-L., Su, T., Lin, Y., Chen, Y., Tung, C.-F., Huang, L., Wu, C.-H., Peng, Y., & Hsieh, V. C. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70259 · Cited by 8
Assessment of Ultra-Early-Stage Liver Fibrosis in Human Non-Alcoholic Fatty Liver Disease by Second-Harmonic Generation Microscopy
Minamikawa, T., Hase, E., Ichimura‐Shimizu, M., Morimoto, Y., Suzuki, A., Yasui, T., Nakamura, S., Tsutsui, A., Takaguchi, K., & Tsuneyama, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063357 · Cited by 8
The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase
Diao, Y., Hu, D., Hu, X., Wang, P., Wang, X., Luo, X., Wang, H., & Ning, Q. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00629-5 · Cited by 8
Mid‐upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic‐associated fatty liver disease: A population based observational study
Wang, X., Li, X., Jin, R., Yang, J., Huang, R., Wei, L., Liu, F., & Rao, H. (2022) · Hepatology Communications · doi:10.1002/hep4.1990 · Cited by 8
Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on long-term survival
Eshraghian, A., Fattahi, M. R., Taghavi, S. A., Shamsaeefar, A., Mansoorian, M., Kazemi, K., Nikeghbalian, S., & Malek‐Hosseini, S. A. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2137488 · Cited by 8
Analysis of clinical features and identification of risk factors in patients with non-alcoholic fatty liver disease based on FibroTouch
Liao, Y., Liu, L., Yang, J., Zhou, X., Teng, X., Li, Y., Wan, Y., Yang, J., & Shi, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-41596-2 · Cited by 8
Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020
Kalligeros, M. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0840 · Cited by 8
Serum Tsukushi Level Is Associated With the Severity of Liver Fibrosis Independent of Type 2 Diabetes
Lam, S., Lee, C., Fong, C. H.-Y., Wong, Y., Shiu, S. W. M., Mak, L., Yuen, M., Lam, K. S. L., & Tan, K. C. B. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad650 · Cited by 8
Association between dietary carbohydrate to fiber ratio and metabolic dysfunction associated fatty liver disease in adults: evidence from the NHANES 2017–2020
Liu, Z., & Fang, T. (2024) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00543-1 · Cited by 8
Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease
Patel, N. H., Lucko, A., Vachon, A., Doucette, K., Ramji, A., Sycuro, L., Patel, T., Chadee, K., Raman, M., van Marle, G., et al. (2024) · Journal of Viral Hepatitis · doi:10.1111/jvh.13979 · Cited by 8
Association between Weight-Adjusted Waist Index and Depression in NAFLD: the modulating roles of sex and BMI
Zhang, J., Wang, Y., Ke, S., Xie, T., Liu, L., Fu, X., Wang, C., & Huang, X. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06308-8 · Cited by 8
Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese and type 2 diabetic populations
Ma, X., Guo, Y.-M., Jiang, S., Li, K., Zheng, Y.-F., Guo, X., & Ren, Z.-Y. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03659-8 · Cited by 8
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease
Iruzubieta, P., González, M., Cabezas, J., Arias-Loste, M. T., & Crespo, J. (2018) · InTech eBooks · doi:10.5772/intechopen.72668 · Cited by 8
How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis
Henry, Z. H., & Argo, C. K. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.09.002 · Cited by 8
Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver disease
Turankova, T. A., Blyuss, O. B., Brazhnikov, A. Y., Svistunov, A. А., Gurusamy, K. S., & Pavlov, C. S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013670 · Cited by 10
ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study
Sekkarie, A., Welsh, J. A., Northstone, K., Cioffi, C. E., Stein, A. D., Figueroa, J., Ramakrishnan, U., & Vos, M. B. (2020) · Children · doi:10.3390/children7090117 · Cited by 8
Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological response
Hsieh, Y., Lee, K., Su, C., Lan, K., Huo, T., Wang, Y., Huang, H.-C., Lin, H., Chu, C., Huang, Y., et al. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000517 · Cited by 8
Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography
Florea, M., Serban, T., Tirpe, G. R., Tirpe, A., & Lupșor‐Platon, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122575 · Cited by 8
A Qualitative Analysis of Mexican-Origin Men’s Knowledge and Cultural Attitudes Toward Non-Alcoholic Fatty Liver Disease and Interest in Risk Reduction
Villavicencio, E. A., Crocker, R. M., & Garcia, D. O. (2021) · American Journal of Men s Health · doi:10.1177/15579883211063335 · Cited by 8
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Dunn, W., Castéra, L., & Loomba, R. S. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.020 · Cited by 8
Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial
Barroso, L. N., Salarini, J. S., Leite, N. C., Villela‐Nogueira, C. A., Dávalos, A., Carmo, M. D. G. T., & Peres, W. A. F. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.06.027 · Cited by 8
Association between micronutrients intake and metabolic-associated fatty liver disease: a cross-sectional study based on the National Health and Nutrition Examination Survey
Hou, J., Wu, Q.-W., & Zhang, L. R. (2023) · Journal of Nutritional Science · doi:10.1017/jns.2023.99 · Cited by 8
Recent advances in noninvasive assessment of liver steatosis
Ferraioli, G., & Barr, R. G. (2024) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16703 · Cited by 8
Self-citation
Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality
Mendes, L. C., Ferreira, P. R. A., Miotto, N., Zanaga, L. P., Lazarini, M. S. K., Gonçales, E. S., Pedro, M. N., Gonçales, F. L., Stucchi, R. S. B., & Vigani, A. G. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001145 · Cited by 8
Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease
Xu, N., Xie, Q., Li, J., Gao, Y., & Xu, L. (2020) · Journal of International Medical Research · doi:10.1177/0300060520903667 · Cited by 8
Noninvasive tools for the assessment of fibrosis in metabolic dysfunction-associated steatotic liver disease
Rigor, J., MARTINS, M. E., Passos, B., Oliveira, R., & Martins‐Mendes, D. (2024) · Minerva Medica · doi:10.23736/s0026-4806.24.09290-5 · Cited by 7
Long-term serum ferritin dynamics in patients receiving antiviral treatment for hepatitis C virus infection
Chang, Y., Huang, C., Kao, J., Su, T., Huang, S., Tseng, T., Chen, P., Liu, C., & Liu, C. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.01.012 · Cited by 7
Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults
Oduwole, O. O., Ding, C., Bitar, N., Nair, D. R., Salter, S., Silverman, M., Allen, R., Fat, L. N., Tsochatzis, E. A., Bell, S., et al. (2025) · npj gut and liver. · doi:10.1038/s44355-025-00024-0 · Cited by 7
Update of machine learning for ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a bright future for deep learning
Li, J., Chen, J., Zeng, X., Lyu, G., Shu, L., & He, S. (2025) · PeerJ · doi:10.7717/peerj.19645 · Cited by 7
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease
Fouad, Y., Elwakil, R., Sanai, F. M., Ojo, O. S., Awadhi, S. A., Ocama, P., Abdelkader, N. A., Al‐Busafi, S. A., Awuku, Y. A., Zaki, S., et al. (2026) · Annals of Hepatology · doi:10.1016/j.aohep.2026.102180 · Cited by 7
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026
Akuta, N., Kogiso, T., Ikejima, K., Otsuka, M., Kawaguchi, T., Kawanaka, M., Takahashi, H., Tamaki, N., Nakagawa, H., 疋田隼人, et al. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02408-2 · Cited by 9
Unmixing multi-spectral electrical impedance tomography (EIT) predicts clinical-standard controlled attenuation parameter (CAP) for nonalcoholic fatty liver disease classification: a feasibility study
Touboul, A., Zouari, F., Minciullo, L., Modak, D., Lee, R. M. V., Wong, E. C., Yuen, M., Seto, W., Mak, L., & Chan, R. W. (2022) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc48229.2022.9871313 · Cited by 7
How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
Seo, D. M., Lee, S. M., Park, J. W., Kim, M.-J., Ha, H. I., Park, S.-Y., & Lee, K. (2022) · ULTRASONOGRAPHY · doi:10.14366/usg.22122 · Cited by 7
Impact of hepatic steatosis on treatment response of autoimmune hepatitis: A retrospective multicentre analysis
Liu, P., Li, M., Zhao, L., Yu, H., Zhao, C., Chen, J., Shi, R., Zhou, L., Zhou, Q., Wu, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1040029 · Cited by 7
Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease
Shahrani, S., Gill, S. S., Sooi, C. Y., Skantha, R., Kumar, C. V. C., Limun, M. F., Affendi, N. A. N. M., Chuah, K. H., Khoo, S., Rajaram, R. B., et al. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16313 · Cited by 7
Self-citation
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial
Shengir, M., Lebouché, B., Elgretli, W., Saeed, S., Ramanakumar, A. V., Giannakis, A., de Pokomandy, A., Cox, J., Costiniuk, C. T., Routy, J., et al. (2023) · HIV Medicine · doi:10.1111/hiv.13531 · Cited by 7
Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States
Guo, Y., Shen, B., Xue, Y., & Li, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1207365 · Cited by 7
The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study
Wu, Z., Huang, K., Bao, S., Zhang, X., Li, J., Kong, W., Shi, Y., & Xie, Y. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2024.2305268 · Cited by 8
Methodology exploration and reproducibility evaluation of TAI and TSI for quantitative ultrasound assessment of hepatic steatosis
Xiao, L., Sun, Z., Liu, W., Sun, L., Ren, J., Xu, Y., Yu, H., & Bai, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31904 · Cited by 7
Food Insecurity in Hispanic Populations Is Associated with an Increased Risk of Hepatic Steatosis: A Nationally Representative Study
Niezen, S., Goyes, D., Vipani, A., Yang, J. D., Ayoub, W. S., Kuo, A., Long, M. T., & Trivedi, H. D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113206 · Cited by 8
Associations of sex-related and thyroid-related hormones with risk of metabolic dysfunction-associated fatty liver disease in T2DM patients
Lu, W., Li, S., Li, Y., Zhou, J., Wang, K., Chen, N., & Li, Z. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01618-0 · Cited by 9
Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial
Stefan, N., Hartleb, M., Popovic, B., & Varona, R. (2024) · Trials · doi:10.1186/s13063-024-08208-4 · Cited by 7
Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases
García-Nieto, E., Rodríguez-Duque, J. C., Rivas, C., Iruzubieta, P., García, M. J., Rasines, L., Álvarez-Cancelo, A., García-Blanco, A., Fortea, J. I., Puente, Á., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101167 · Cited by 8
Gut phageome in Mexican Americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes
Kwan, S., Sabotta, C. M., Cruz, L. R., Wong, M. C., Ajami, N. J., McCormick, J. B., Fisher‐Hoch, S. P., & Beretta, L. (2024) · mSystems · doi:10.1128/msystems.00434-24 · Cited by 7
Anti-inflammatory diet reduces risk of metabolic dysfunction-associated fatty liver disease among US adults: a nationwide survey
Hu, W., Luo, L., Li, M., Xiong, X., Wenlong, H., Huang, Y., Sun, J., Ding, H., & Yu, H. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2024.2395851 · Cited by 7
Endoscopic sleeve gastroplasty for metabolic dysfunction-associated steatotic liver disease
Matteo, M. V., Gualtieri, L., Bove, V., Palumbo, G., Pontecorvi, V., Siena, M. D., Barbaro, F., Spada, C., & Boškoski, I. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2387231 · Cited by 7
Epidemiological Study on the Interaction between the PNPLA3 (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease
Sato, S., Iino, C., Sasada, T., Soma, G., Furusawa, K., Yoshida, K., Sawada, K., Mikami, T., Nakaji, S., Sakuraba, H., et al. (2024) · Genes · doi:10.3390/genes15091172 · Cited by 7
Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease
Dong, R., Tian, T., Luo, Z., Chang, D., Xue, H., Qu, S., Wang, J., Shen, C. Q., Zhang, R., & Wang, J. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.103797 · Cited by 7
Development and validation of a new diagnostic prediction model for NAFLD based on machine learning algorithms in NHANES 2017-2020.3
Wang, Y., & Wang, P. (2025) · HORMONES · doi:10.1007/s42000-025-00634-6 · Cited by 7
How to Approach a Patient With Nonalcoholic Fatty Liver Disease
Tilg, H. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.016 · Cited by 7
Effects of Gene Variants Controlling Vitamin D Metabolism and Serum Levels on Hepatic Steatosis
Jamka, M., Arslanow, A., Bohner, A., Krawczyk, M. J., Weber, S. N., Grünhage, F., Lammert, F., & Stokes, C. S. (2018) · Digestion · doi:10.1159/000485180 · Cited by 7
Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
Ni, X., Lian, M., Wu, H., Li, X., Li, S., Bao, H., Miao, Q., Xiao, X., Guo, C., Li, H., et al. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i1.80 · Cited by 7
Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases
Cardoso, A. C., Villela‐Nogueira, C. A., de Figueiredo-Mendes, C., Filho, H. L., Pinto-Silva, R. A., Tovo, C. V., Perazzo, H., Matteoni, A. C., de Carvalho‐Filho, R. J., & Bittencourt, P. L. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100341 · Cited by 7
Self-citation
Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort
Sekkarie, A., Welsh, J. A., Northstone, K., Stein, A. D., Ramakrishnan, U., & Vos, M. B. (2021) · Children · doi:10.3390/children8040290 · Cited by 7
Controlled attenuation parameter measured using transient elastography for the noninvasive assessment of macrovesicular steatosis in potential living liver donors
Lee, S., Kim, K. W., Kim, S. Y., Seo, N., Song, G., & Lee, S. (2021) · ULTRASONOGRAPHY · doi:10.14366/usg.21071 · Cited by 7
A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease
Tao, X., Chen, L., Zhao, Y., Liu, Y., Shi, R., Jiang, B., Mi, Y., & Xu, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.862879 · Cited by 7
Self-citation
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
Gracen, L., Hayward, K. L., Aikebuse, M., Russell, A. W., O’Beirne, J. P., McPhail, S., Irvine, K. M., Williams, S., Valery, P. C., & Powell, E. E. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07808-7 · Cited by 7
Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study
Tateda, T., Iino, C., Sasada, T., Sato, S., Igarashi, G., Kawaguchi, S., Mikami, K., Endo, T., Sawada, K., Mikami, T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277930 · Cited by 8
The diagnostic value of novel ultrasound attenuation analysis in detecting liver steatosis identified by the controlled attenuation parameter: a diagnostic accuracy study
Jiang, M., Zhang, X., Wu, X., Xu, Z., Pan, J., He, H., Luo, Y., & Chen, J. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-5821 · Cited by 7
Ultraschallgeräte für die abdominelle Diagnostik: neue Techniken und Applikationen – Was gibt es? Was ist möglich? Was ist sinnvoll?
Karlas, T., Blank, V., Trenker, C., Ignee, A., & Dietrich, C. F. (2023) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1993-5356 · Cited by 7
Self-citation
Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography
Wiafe, Y. A., Afihene, M., Anto, E. O., Nmai, R. A., Amoah-Kumi, L., Frimpong, J., Dickson, F. D., Antwi, S. O., & Roberts, L. R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113741 · Cited by 36
Association between carotenoid intake and metabolic dysfunction-associated fatty liver disease among US adults: A cross-sectional study
Zhang, H., Li, L., Jia, L., & Liu, J. (2023) · Medicine · doi:10.1097/md.0000000000036658 · Cited by 7
Reflection Measurement of the Scattering Mean Free Path at the Onset of Multiple Scattering
Goïcoechea, A., Brütt, C., Ber, A. L., Bureau, F., Lambert, W., Prada, C., Derode, A., & Aubry, A. (2024) · Physical Review Letters · doi:10.1103/physrevlett.133.176301 · Cited by 7
Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B
Sharif, A., Abbas, Z., Ahmed, S., Samjo, S. A., & Baqai, K. (2019) · Cureus · doi:10.7759/cureus.5995 · Cited by 7
Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
Fernández‐Fuertes, M., Macı́as, J., Corma‐Gómez, A., Rincón, P., Merchante, N., Gómez-Mateos, J. M., Pineda, J. A., & Real, L. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-62671-y · Cited by 7
Shear Wave Elastography and Shear Wave Dispersion Imaging in the Assessment of Liver Disease in Alpha1-Antitrypsin Deficiency
Schulz, M., Kleinjans, M., Strnad, P., Demir, M., Holtmann, T. M., Tacke, F., & Wree, A. (2021) · Diagnostics · doi:10.3390/diagnostics11040629 · Cited by 7
Pi*ZZ-related liver disease in children and adults—narrative review of the typical presentation and management of alpha-1 antitrypsin deficiency
Katzer, D., Ganschow, R., Strnad, P., & Hamesch, K. (2021) · Digestive Medicine Research · doi:10.21037/dmr-21-9 · Cited by 7
Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis
Trivedi, H. D., Niezen, S., Jiang, Z. G., & Tapper, E. B. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07228-3 · Cited by 7
Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease
Ciaula, A. D., Shanmugam, H., Ribeiro, R. T., Pina, A. F., Andrade, R., Bonfrate, L., Raposo, J. F., Macedo, M. P., & Portincasa, P. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.10.024 · Cited by 7
Work up of fatty liver by primary care physicians, review
Rikhi, R. R., Singh, T., & Esfeh, J. M. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.01.001 · Cited by 7
Alpha-1 antitrypsin deficiency
Fromme, M., & Strnad, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00005-7 · Cited by 7
First-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode (CUTE)Preprint
Stähli, P., Becchetti, C., Martiartu, N. K., Berzigotti, A., Frenz, M., & Jaeger, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1920871/v1 · Cited by 7
Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD)
Li, X., Xiao, Y., Chen, X., Zhu, Y., Du, H., Shu, J. H., Yu, H., Ren, X., Zhang, F., Dang, J., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00204 · Cited by 6
Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease
Yin, H., Fan, Y., Yu, J., Xiong, B., Zhou, B., Sun, Y.-K., Wang, L., Zhu, Y., & Xu, H. (2024) · Insights into Imaging · doi:10.1186/s13244-024-01728-2 · Cited by 6
Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review
Arteaga, Í., Chacón, C., Martínez-Escudé, A., Ruiz-Rojano, I., Diez-Fadrique, G., Carmona-Cervelló, M., & Torán‐Monserrat, P. (2025) · Diagnostics · doi:10.3390/diagnostics15030299 · Cited by 7
Association between triglyceride-glucose related indices and at-risk NASH in U.S. adults with NAFLD: results from NHANES 2017-2020
Ma, H., Zhang, W., Zhao, Z., Jin, S., Li, L., Zong, R., Li, W., Zhang, Z., Cui, S., Pan, Y., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1604991 · Cited by 6
Liver hypertrophy techniques: a position paper from the Italian Group of Regenerative and Occlusive Worldwide-used techniques of hepatic Hypertrophy (I GROWtoH)
Serenari, M., Ratti, F., Hilal, M. A., Ardito, F., Berardi, G., Boggi, U., Cappelli, A., Cescon, M., Cillo, U., Cucchetti, A., et al. (2025) · Updates in Surgery · doi:10.1007/s13304-025-02364-1 · Cited by 6
Continuous glucose monitoring: criteria for the diagnosis of type 2 diabetes mellitus with clinical obesity after gestational diabetes
Fernández, C. G., Mitsigiorgi, R., Fochini, M., Leung, A., Pérez, C. F., & Nicolaides, K. H. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.09.031 · Cited by 6
Burden of MASLD and liver fibrosis: evidence from Phenome India cohort
Arvind, M., Verma, A., K, S., Prakash, S., Kumar, V., Uddin, M. A., Narayan, A., Rathore, M., Rawat, N., Sahu, A., et al. (2026) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2026.100723 · Cited by 9
A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study
Kumar, A., Panda, J. K., Agrawal, P., Gupta, S., Kumar, D., Kuchay, M. S., Kesavadev, J., Mohan, V., Jagadeesha, A., Saboo, B., et al. (2026) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2026.100753 · Cited by 6
Effect of Essential Phospholipids in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial
Stefan, N., Hartleb, M., Fan, J., Demir, M., Schattenberg, J. M., Gietka, J., Bułdak, Ł., Popovic, B., Varona, R., & Fer, B. B. D. (2026) · Liver International · doi:10.1111/liv.70601 · Cited by 6
Self-citation
Longitudinal associations of total and trunk fat in childhood and adolescence and risk of hepatic steatosis at 24 years
Cohen, C. C., Sekkarie, A., Figueroa, J., Gillespie, S. E., Vos, M. B., & Welsh, J. A. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12773 · Cited by 6
Ultrasound Elastography—Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease Assessment
Hari, A. (2021) · Medicina · doi:10.3390/medicina57060516 · Cited by 6
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients
Sebastiani, G., Milić, J., Cervo, A., Saeed, S., Krahn, T., Kablawi, D., Hinai, A. S. A., Lebouché, B., Wong, P. Y. N., Deschênes, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020282 · Cited by 6
Non‐alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension
Pirola, C. J., & Sookoian, S. C. (2023) · Liver International · doi:10.1111/liv.15643 · Cited by 6
Prevalence of hepatic steatosis and fibrosis in apparently healthy airline pilots: a transient elastography study
Minoretti, P., Sáez, A. S. S., Martín, Á. F. G., Riera, M. L., Serrano, M. G., & Emanuele, E. (2023) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2023.2023.0050 · Cited by 6
Serum thrombospondin‐2 level changes with liver stiffness improvement in patients with type 2 diabetes
Mak, J. H., Lui, D. T. W., Fong, C. H.-Y., Cheung, C. Y. Y., Wong, Y., Lee, A. C., Hoo, R. L. C., Xu, A., Tan, K. C. B., Lam, K. S. L., et al. (2023) · Clinical Endocrinology · doi:10.1111/cen.15010 · Cited by 6
Response to semaglutide of non-drinker subjects with type 2 diabetes
Petralli, G., Raggi, F., Zoppo, A. D., Rovera, C., Salvati, A., Brunetto, M. R., & Solini, A. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01344-6 · Cited by 6
Correlation between controlled attenuation parameter values with SYNTAX score in patients with significant coronary artery disease
Sardjan, J., Lesmana, C. R. A., Rusdi, L., Kurniawan, J., Yunihastuti, E., Susilo, A., & Gani, R. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-63792-4 · Cited by 6
The fibrosis investigating navigator in diabetes ( FIND ): A tool to predict liver fibrosis risk in subjects with diabetes
Li, M., Yu, H., Wan, S., Hu, F., Luo, Q., & Gong, W. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16109 · Cited by 6
Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis
Contreras, A. D. C., Francisco, M. D. R. R., Basurto, J. L. V., González-Gómez, K. D., Amieva‐Balmori, M., Dietlen, F. B. R., & Remes-Troche, J. M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i1.101704 · Cited by 6
Estimated sdLDL-C as a biomarker of hepatic steatosis severity in MASLD: a retrospective study
Jiang, S., Zhang, F., Yang, H., Han, X., Mao, J., Zheng, G., & Fan, Y. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03759-5 · Cited by 6
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals
Shengir, M., Elgretli, W., Cinque, F., Ramanakumar, A. V., Lombardi, R., Cespiati, A., Fracanzani, A. L., Ballesteros, L. R., Deschênes, M., Wong, P. Y. N., et al. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102639 · Cited by 6
Validation of the American Association for the Study of Liver Disease/European Association for the Study of the Liver Multistep Screening Strategies for Metabolic Dysfunction-associated Steatotic Liver disease
Canivet, C. M., Ongaro, M., Conquet, N., Spahr, L., & Goossens, N. (2025) · Gastro Hep Advances · doi:10.1016/j.gastha.2025.100747 · Cited by 6
Noninvasive Evaluation of Fibrosis and Steatosis in Nonalcoholic Fatty Liver Disease by Elastographic Methods
Lupșor‐Platon, M. (2018) · InTech eBooks · doi:10.5772/intechopen.71161 · Cited by 6
Vibration-Guided Transient Elastography: A Novel Fibroscan® Examination with Improved Guidance for Liver Stiffness Measurement
Lorée, H., Bastard, C., Miette, V., & Sandrin, L. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.04.010 · Cited by 6
Controlled attenuation parameter value-based diagnostic algorithm improves the accuracy of liver stiffness measurement in chronic hepatitis B patients
Fan, Y., Wang, L., Ding, Y., Sheng, Q., Zhang, C., Li, Y., Han, C. Q., & Dou, X. (2020) · Aging · doi:10.18632/aging.103522 · Cited by 6
The Role of Elastography in Non-Alcoholic Fatty Liver Disease.
Constantinescu, C., Săndulescu, L., & Săftoiu, A. (2020) · PubMed Central · doi:10.12865/chsj.46.03.07 · Cited by 8
Clinical relevance of environmental manganese exposure with liver stiffness and steatosis detected by transient elastography in adults
Liu, X., Shen, H., Chen, M., & Shao, J. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17012-5 · Cited by 6
Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes
Jojima, T., Kurai, H., Tanuma, D., Kajitani, H., Kase, M., Inoue, Y., Sakurai, S., Iijima, T., Tomaru, T., Usui, I., et al. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.101071 · Cited by 6

Authors: Karlas, T., Petroff, D., Sasso, M., Fan, J.-G., Mi, Y.-Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.-H., Cardoso, A. C., Ferraioli, G., Chan, W.-K., Wong, V. W.-S., Myers, R. P., Chayama, K., Friedrich-Rust, M., Beaugrand, M., Shen, F., Hiriart, J.-B., Sarin, S. K., Badea, R., Jung, K. S., Marcellin, P., Filice, C., Mahadeva, S., Wong, G. L.-H., Crotty, P., Masaki, K., Bojunga, J., Bedossa, P., Keim, V., & Wiegand, J.
Affiliations: University Hospital Leipzig (DE)
IFB Adiposity Diseases (DE)
Echosens (France) (FR)
Shanghai Jiao Tong University (CN)
Institute of Liver and Biliary Sciences (IN)
Yonsei University (KR)
Inserm (FR)
University of Pavia (IT)
University of Malaya (MY)
Chinese University of Hong Kong (HK)
University of Calgary (CA)
Hiroshima University Hospital (JP)
Hôpital Jean-Verdier (FR)
Centre Hospitalier Universitaire de Bordeaux (FR)
Iuliu Hațieganu University of Medicine and Pharmacy (RO)
University Hospital Frankfurt (DE)
Corresponding author: Wiegand, Johannes
ORCID: Karlas, Thomas
Petroff, David
Sasso, Magali
Fan, Jian-Gao
Kumar, Manoj
Han, Kwang-Hyub
Cardoso, Ana C.
Ferraioli, Giovanna
Chan, Wah-Kheong
Wong, Vincent Wai-Sun
Chayama, Kazuaki
Shen, Feng
Hiriart, Jean-Baptiste
Sarin, Shiv K.
Badea, Radu
Marcellin, Patrick
Mahadeva, Sanjiv
Wong, Grace Lai-Hung
Crotty, Pam
Bojunga, Joerg
Wiegand, Johannes
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2017-05
Volume: 66
Issue: 5
Pages: 1022-1030
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2016.12.022
OpenAlex: W2564467149
Cited by: 1,275
References: 65
Citations by year: 2026: 164 · 2025: 185 · 2024: 180 · 2023: 139 · 2022: 161 · 2021: 150 · 2020: 117 · 2019: 77 · 2018: 67 · 2017: 31
FWCI: 7.94
Type: journal article
Language: en
Open access: green
www.sciencedirect.com
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Ultrasound in Clinical Applications
Keywords: controlled attenuation parameter, hepatic steatosis, vibration-controlled transient elastography, FibroScan, chronic liver disease, diabetes mellitus, body mass index, liver ultrasound, receiver operating characteristic
MeSH terms: Adult, Fatty Liver, Female, Humans, Male, Middle Aged, ROC Curve, Ultrasonography, Meta-Analysis as Topic, Body Mass Index, Hepatocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks